Sponsored By

Gemini Pharmaceuticals Expands Capabilities to Offer Clients Non-GMO Project Verified Products

Gemini Pharmaceuticals announced today it has participated as the Handler in the verification of a client’s product to the standard established by the Non-GMO Project. The certification was provided by NSF International as the Technical Administrator for the Non-GMO Project.

April 11, 2017

1 Min Read
Gemini Pharmaceuticals Expands Capabilities to Offer Clients Non-GMO Project Verified Products

Press Release

COMMACK, NY (APRIL 11, 2017) — Gemini Pharmaceuticals, a 30+ year-old contract manufacturer of dietary supplements and OTC pharmaceuticals, announced today it has participated as the Handler in the verification of a client’s product to the standard established by the Non-GMO Project. The certification was provided by NSF International as the Technical Administrator for the Non-GMO Project.

“This is affirmation by the leading organizations that we provide non- GMO products to the market, and verifies that both our supply chain, vendor relations and our internal manufacturing and quality operations can provide repeatable, verifiable products for our customers avoiding GMO’s,” stated Mike Finamore, Chief Executive Officer of Gemini.

He added, “This, combined with our other cGMP registrations, gives Gemini client’s assurance that their products are made to the highest industry standards.”
“Verification to the Non-GMO Project standards assures the integrity the product claims,” said Nancy Knight, Business Unit Manager, QAI, Inc, an NSF International organization. “We welcome Gemini Pharmaceutical’s verification to the Non-GMO Project standard, which can provide customers peace of mind knowing the manufacturing, ingredients, and products they produced meet the rigorous verification standards.”

For more information, visit www.geminipharm.com

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like